Skip to main content

Search

Reset all filters
403 Result(s)
Sort by

New initiative elevates the importance of CKD testing

New initiative elevates the importance of CKD testing

Boehringer Ingelheim and Lilly team up with hip-hop artist Rob Base for the launch of It Takes 2™ – a new health initiative to educate healthcare professionals and adults at risk for kidney disease on the condition’s unknown nature and the benefits of com
Dr. Anna Dieckmann and Dr. Lorenz Maier

Dr. Anna Dieckmann and Dr. Lorenz Maier

Here is the story of Dr. Anna Dieckmann and Dr. Lorenz Maier's successful partnership. For more talent insights, visit our Careers Page.
Learning and development

Learning and development

We help people grow professionally by maximizing our talent and giving them room to evolve within the company.
Rewards and recognition

Rewards and recognition

There are achievements and occasions that demand recognition. We go out of way to give employees tangible rewards and more for business milestones.
Andreas Lenk

Andreas Lenk

Andreas Lenk, Head of Legal and Compliance Germany, discusses his role supporting human pharma and animal health business in legal and compliance matters.
Alexander Guntur

Alexander Guntur

Alexander Guntur, Information Protection and Security officer in Singapore, describes his 14 years with the company as fulfilling.
Ridgefield Research and Innovation

Ridgefield Research and Innovation

Ridgefield, CT, USA is Boehringer Ingelheim's 3rd largest research sit, where scientists are tackling some of the most difficult challenges in healthcare.
FDA approved treatment option for adults with CKD

FDA approved treatment option for adults with CKD

The FDA has approved Jardiance® (empagliflozin) tablets to reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR), end-stage kidney disease, cardiovascular death and hospitalization in adults with CKD at risk of progression.